在患有食道状细胞癌的患者中,用于术后复发的放射治疗和化学放射治疗
Qing Liu1, Xue-Hua Tu2, Rui-Xuan Yu3
1Integrated Care Management Center, West China Hospital, Sichuan University, Chengdu, China.
Cancer medicine
|August 20, 2024
概括
对于食道状细胞癌 (ESCC) 患者,有复发性疾病,化学放射治疗 (CRT) 可能有利于阴性淋巴结患者,而放射治疗 (RT) 建议用于阳性淋巴结患者.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 手术瘤学手术瘤学
背景情况:
- 在术后对复发性食道状细胞癌 (ESCC) 的最佳治疗方法进行了辩论.
- 放射治疗 (RT) 和化学放射治疗 (CRT) 是潜在的救援选择.
研究的目的:
- 为了评估救援RT与CRT在ESCC患有术后复发的患者中的疗效.
- 确定影响复发后生存 (PRS) 的预后因素.
主要方法:
- 对接受救援RT或CRT (2015-2019) 的170名ESCC患者的回顾性审查.
- 对于预后因素的PRS和Cox模型的Kaplan-Meier分析.
- 基于淋巴结 (LN) 状态的亚组分析 (阴性/阳性).
主要成果:
- 整体而言,RT和CRT之间的PRS中位数没有显著差异 (p > 0.05).
- TNM III/IV阶段,髓型和远程转移是独立的负预后因素.
- 在节点阴性患者中,CRT改善了类似毒性的生存率 (p=0.043).
- 在节点阳性患者中,RT显示出更好的预后 (p=0.020) 和较低的毒性 (p=0.030).
结论:
- 化学辐射疗法 (CRT) 对节点阴性复发ESCC患者有益.
- 对于节点阳性复发ESCC患者,建议进行放射治疗 (RT),因为结果更好,毒性更低.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
131
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
131
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Esophageal Strictures-I: Introduction
70
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
70
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
Esophageal Strictures-II: Clinical Features and Management
57
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
57
Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62


